Key points are not available for this paper at this time.
Key Points FF-10101 has selective and potent inhibitory activities against FLT3 by forming a covalent bond to the C695 residue. FF-10101 shows high efficacy against AML cells with FLT3 mutations including quizartinib-resistant activation loop mutations.
Yamaura et al. (Wed,) studied this question.